{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:11:33Z","timestamp":1709889093928},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<jats:p>&lt;p&gt;&lt;strong&gt;ABSTRACT&lt;\/strong&gt;&lt;br \/&gt;&lt;strong&gt;BACKGROUND&lt;\/strong&gt;. Chickenpox is a common disease in Poland, which is usually mild, but can lead to serious\u00a0complications. Vaccination is an effective form of prevention. Before the introduction of universal vaccination\u00a0against chickenpox, high incidence was recorded in many countries. In Poland, since 2003, vaccinations are\u00a0recommended for people who did not get sick, and since 2009, compulsory for children up to 12 years of age\u00a0particularly exposed to infection and children from their surroundings.&lt;br \/&gt;&lt;strong&gt;AIM&lt;\/strong&gt;. To assess epidemiological situation of chickenpox in Poland in 2017, including vaccination coverage in\u00a0Polish population, in comparison to previous years.&lt;br \/&gt;&lt;strong&gt;METHODS&lt;\/strong&gt;. Assessment of the epidemiological situation of chickenpox in Poland in 2017. was based on the\u00a0results of the analysis of aggregate data published in the annual bulletins: \u201cInfectious diseases and poisoning\u00a0in Poland in 2017\u201d and \u201cProtective Vaccination in Poland in 2017. In addition, the recommendations from the\u00a0Protective Vaccine Program for 2017 were used.&lt;br \/&gt;&lt;strong&gt;RESULTS&lt;\/strong&gt;. In 2017, 173 196 cases of chickenpox were registered in Poland, 7.21% more than in the previous\u00a0year. The incidence of varicella in 2017 was 450.8 per 100,000. and was higher than in 2016 . The lowest incidence\u00a0was registered in the Dolno\u015bl\u0105skie voivodeship \u2013 324.6\/ 100,000, the highest in the Opolskie voivodeship \u2013\u00a0601.0 \/ 100,000. The most incidence was observed among children aged 0-4 years (88 711). Incidence in men\u00a0was higher than in women, and the rural population higher than for urban residents. In 2017, 1200 people were\u00a0hospitalized due to chickenpox. 75 040 people were vaccinated against varicella.&lt;br \/&gt;&lt;strong&gt;SUMMARY&lt;\/strong&gt;. In 2017, there was a slight increase in the number of smallpox cases compared to the previous year,\u00a0however, the incidence remains lower than in 2012-2014. An effective method of preventing it is chickenpox\u00a0vaccination, which despite the lack of universal funding is being carried out in ever greater population. Further\u00a0improvement of the epidemiological situation requires public health education in the field of primary prevention\u00a0based on vaccination. As recommended, the smallpox vaccination course includes two doses of the vaccine at\u00a0least 6 weeks apart from the previous dose.&lt;\/p&gt;\n&lt;p&gt;&lt;strong&gt;STRESZCZENIE&lt;\/strong&gt;&lt;br \/&gt;&lt;strong&gt;WST\u0118P&lt;\/strong&gt;. Ospa wietrzna jest w Polsce chorob\u0105 cz\u0119sto wyst\u0119puj\u0105c\u0105, kt\u00f3ra zwykle przebiega \u0142agodnie, ale mo\u017ce\u00a0prowadzi\u0107 do powa\u017cnych powik\u0142a\u0144. Skuteczn\u0105 form\u0105 zapobiegania s\u0105 szczepienia. Przed wprowadzeniem powszechnego\u00a0szczepienia przeciwko ospie wietrznej w wielu krajach rejestrowano wysok\u0105 zapadalno\u015b\u0107.&lt;br \/&gt;W Polsce od 2003 r. s\u0105 to szczepienia zalecane dla os\u00f3b, kt\u00f3re nie chorowa\u0142y oraz od 2009 r. obowi\u0105zkowe dla\u00a0dzieci do 12 r. \u017c. nara\u017conych w spos\u00f3b szczeg\u00f3lny na zaka\u017cenie i dzieci z ich\u00a0 otoczenia.&lt;br \/&gt;&lt;strong&gt;CEL PRACY&lt;\/strong&gt;. Celem pracy by\u0142a ocena sytuacji epidemiologicznej ospy wietrznej w Polsce w 2017 r. oraz por\u00f3wnanie\u00a0z sytuacj\u0105 w poprzednich latach.&lt;br \/&gt;&lt;strong&gt;MATERIA\u0141 I METODY&lt;\/strong&gt;. Ocen\u0119 sytuacji epidemiologicznej ospy wietrznej w Polsce w 2017 r. przeprowadzono\u00a0na podstawie wynik\u00f3w analizy danych zbiorczych opublikowanych w rocznych biuletynach:\u00a0\u201eChoroby zaka\u017ane i zatrucia w Polsce w 2017 r.\u201d oraz \u201eSzczepienia Ochronne w Polsce w 2017 r.\u201d. Ponadto\u00a0wykorzystano zalecenia z Programu Szczepie\u0144 Ochronnych na 2017 r.&lt;br \/&gt;&lt;strong&gt;WYNIKI&lt;\/strong&gt;. W 2017 r. w Polsce zarejestrowano 173 196 zachorowa\u0144 na osp\u0119 wietrzn\u0105, tj. o 7,21% wi\u0119cej ni\u017c\u00a0w roku poprzednim. Zapadalno\u015b\u0107 na osp\u0119 wietrzn\u0105 w roku 2017 wynosi\u0142a 450,8 na 100 tys. i by\u0142a wy\u017csza ni\u017c\u00a0w 2016 r. Najni\u017csz\u0105 zapadalno\u015b\u0107 zarejestrowano w wojew\u00f3dztwie dolno\u015bl\u0105skim \u2013 324,6\/100 tys., najwy\u017csz\u0105\u00a0w wojew\u00f3dztwie opolskim \u2013 601,0\/ 100 tys. Najwi\u0119cej zachorowa\u0142o dzieci w wieku 0-4 lata (88 711). Zapadalno\u015b\u0107\u00a0na osp\u0119 wietrzn\u0105 m\u0119\u017cczyzn by\u0142a wy\u017csza ni\u017c kobiet, a mieszka\u0144c\u00f3w wsi wy\u017csza ni\u017c mieszka\u0144c\u00f3w miast.&lt;br \/&gt;Hospitalizacja z powodu ospy wietrznej w 2017 r obj\u0119\u0142a 1 200 os\u00f3b, co stanowi\u0142o 0,69% og\u00f3\u0142u liczby zarejestrowanych\u00a0zachorowa\u0144. Zaszczepiono przeciw ospie wietrznej 68989 os\u00f3b.&lt;br \/&gt;&lt;strong&gt;PODSUMOWANIE&lt;\/strong&gt;. W 2017 r. wyst\u0105pi\u0142 niewielki wzrost liczby zachorowa\u0144 na osp\u0119 w por\u00f3wnaniu z poprzednim\u00a0rokiem, jednak zapadalno\u015b\u0107 pozostaje na poziomie ni\u017cszym ni\u017c w latach 2012-2014.Skuteczn\u0105 metod\u0105\u00a0zapobiegania zachorowaniom s\u0105 szczepienia przeciw ospie, kt\u00f3re pomimo braku powszechnego finansowania\u00a0s\u0105 wykonywane u coraz wi\u0119kszej populacji. Dalsza poprawa sytuacji epidemiologicznej wymaga edukacji zdrowotnej\u00a0spo\u0142ecze\u0144stwa w zakresie profilaktyki pierwszorz\u0119dowej, kt\u00f3rej fundament stanowi\u0105 szczepienia.&lt;br \/&gt;Zgodnie z zaleceniami cykl szczepie\u0144 przeciw ospie obejmuje podanie dw\u00f3ch dawek szczepionki w odst\u0119pie co\u00a0najmniej 6 tygodni od poprzedniej dawki.&lt;\/p&gt;<\/jats:p>","DOI":"10.32394\/pe.73.38","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T14:29:29Z","timestamp":1582727369000},"page":"411-416","source":"Crossref","is-referenced-by-count":0,"title":["Chickenpox in Poland in 2017"],"prefix":"10.32394","volume":"73","author":[{"given":"J","family":"Bogusz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Paradowska-Stankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2020,1,15]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["Ospa wietrzna w Polsce w 2017 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-180897-101454","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-180897-101454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:45:58Z","timestamp":1709887558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Chickenpox-in-Poland-in-2017,180897,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["180897"],"URL":"https:\/\/doi.org\/10.32394\/pe.73.38","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]}}}